Listed

Natural Health Trends Corp

NHTCNasdaqCIK 912061Consumer discretionaryFiscal year ends Dec 31

Latest reported revenue, Q3 FY2026$7.6mRevenue, Q3 FY2026, three months to 2026-09-30$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 28, 2026.

Latest quarter: Q3 FY2026

Three months to Sep 30, 2026, against the same quarter a year earlier.

  • Revenue$7.6mRevenue, Q3 FY2026, three months to 2026-09-30$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure−20.2% on a year earlier
  • Gross margin74.2%Gross margin, Q3 FY2026, three months to 2026-09-30. gross profit / revenueGross profit: $5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure+0.4 pts on a year earlier
  • Operating margin−3.7%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: −$277.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure+1.6 pts on a year earlier
  • Net margin−3.1%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: −$232.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure+1.5 pts on a year earlier
  • Diluted EPS−$0.03Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure+25.0% on a year earlier
  • Free cash flow−$1.1mFree cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: −$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Capital expenditure: $7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$7.6mGross margin 74.2%
Diluted EPS−$0.03, Q3 FY2026
Free cash flow−$1.1m, Q3 FY2026
Natural Health Trends Corp, key figures for the last eight quarters
Line itemUnitQ4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30Shape over the periods
Revenue$m10.8Revenue, Q4 FY2024, three months to 2024-12-31$10.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure10.7Revenue, Q1 FY2025, three months to 2025-03-31$10.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure9.8Revenue, Q2 FY2025, three months to 2025-06-30$9.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure9.5Revenue, Q3 FY2025, three months to 2025-09-30$9.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure9.7Revenue, Q4 FY2025, three months to 2025-12-31$9.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure9.2Revenue, Q1 FY2026, three months to 2026-03-31$9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure7.6Revenue, Q2 FY2026, three months to 2026-06-30$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure7.6Revenue, Q3 FY2026, three months to 2026-09-30$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Gross margin%74.2%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $8.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Revenue: $10.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure73.6%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $7.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Revenue: $10.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure73.9%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $7.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Revenue: $9.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure73.7%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $7.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $9.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure72.9%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $7.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Revenue: $9.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure75.0%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $6.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Revenue: $9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure75.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $5.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure74.2%Gross margin, Q3 FY2026, three months to 2026-09-30. gross profit / revenueGross profit: $5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Operating margin%(3.9%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$421.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Revenue: $10.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(3.2%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$345.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Revenue: $10.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(3.4%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$333.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Revenue: $9.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(5.2%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$495.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $9.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure(6.5%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$635.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Revenue: $9.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(5.1%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$474.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Revenue: $9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(8.5%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$643.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(3.7%)Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: −$277.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Net margin%1.6%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $176.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Revenue: $10.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure1.1%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $122.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $10.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure0.2%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $15.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $9.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(4.5%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$431.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $9.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure(6.0%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$588.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Revenue: $9.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(1.7%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$154.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(5.9%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$451.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(3.1%)Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: −$232.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Revenue: $7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)0.01Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure0.00Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(0.04)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figurenot reported (Diluted EPS not reported)(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(0.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001437749-26-024770.Report this figure(0.03)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-28, accession 0001437749-26-033713.Report this figure
Free cash flow$m0.1Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $88.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Capital expenditure: $20.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure0.5Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $484.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Capital expenditure: $16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(5.6)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$5.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Capital expenditure: $4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure0.1Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $113.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Capital expenditure: $43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figure(1.0)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$959.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Capital expenditure: $5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001437749-26-004876. Derived: 12-month figure less the 9-month figure.Report this figure(0.9)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$797.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Capital expenditure: $115.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0001437749-26-013744.Report this figure(1.7)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Capital expenditure: $325.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001437749-26-024770. Derived: 6-month figure less the 3-month figure.Report this figure(1.1)Free cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: −$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Capital expenditure: $7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-28, accession 0001437749-26-033713. Derived: 9-month figure less the 6-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$39.8mGross margin 73.5%
Diluted EPS−$0.08, FY2025
Free cash flow−$6.1m, FY2025
Natural Health Trends Corp, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m60.0Revenue, FY2021, twelve months to 2021-12-31$60.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-03, accession 0001437749-23-005365.Report this figure49.1Revenue, FY2022, twelve months to 2022-12-31$49.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001437749-24-005850.Report this figure43.9Revenue, FY2023, twelve months to 2023-12-31$43.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure43.0Revenue, FY2024, twelve months to 2024-12-31$43.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure39.8Revenue, FY2025, twelve months to 2025-12-31$39.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure
Gross margin%75.0%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $45.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-03, accession 0001437749-23-005365.Revenue: $60.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-03, accession 0001437749-23-005365.Report this figure74.2%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $36.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-28, accession 0001437749-24-005850.Revenue: $49.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001437749-24-005850.Report this figure74.6%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $32.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-21, accession 0001437749-25-004700.Revenue: $43.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure74.0%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $31.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-20, accession 0001437749-26-004876.Revenue: $43.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure73.5%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $29.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-20, accession 0001437749-26-004876.Revenue: $39.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure
Operating margin%2.6%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-03, accession 0001437749-23-005365.Revenue: $60.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-03, accession 0001437749-23-005365.Report this figure(0.5%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$270.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-28, accession 0001437749-24-005850.Revenue: $49.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001437749-24-005850.Report this figure(3.8%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-21, accession 0001437749-25-004700.Revenue: $43.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure(3.0%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876.Revenue: $43.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure(4.5%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876.Revenue: $39.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure
Net margin%1.8%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-03, accession 0001437749-23-005365.Revenue: $60.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-03, accession 0001437749-23-005365.Report this figure0.6%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $313.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-28, accession 0001437749-24-005850.Revenue: $49.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001437749-24-005850.Report this figure1.3%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $568.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-21, accession 0001437749-25-004700.Revenue: $43.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure1.3%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $572.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876.Revenue: $43.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure(2.2%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$882.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001437749-26-004876.Revenue: $39.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure
Diluted EPS$ per share0.09Diluted EPS, FY2021, twelve months to 2021-12-31$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-03, accession 0001437749-23-005365.Report this figure0.03Diluted EPS, FY2022, twelve months to 2022-12-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-28, accession 0001437749-24-005850.Report this figure0.05Diluted EPS, FY2023, twelve months to 2023-12-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure0.05Diluted EPS, FY2024, twelve months to 2024-12-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure(0.08)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure
Free cash flow$m0.8Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $1.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-03, accession 0001437749-23-005365.Capital expenditure: $225.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-03, accession 0001437749-23-005365.Report this figure(5.0)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-28, accession 0001437749-24-005850.Capital expenditure: $143.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-28, accession 0001437749-24-005850.Report this figure(4.3)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-21, accession 0001437749-25-004700.Capital expenditure: $46.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-21, accession 0001437749-25-004700.Report this figure(3.4)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001437749-26-004876.Capital expenditure: $57.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure(6.1)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001437749-26-004876.Capital expenditure: $68.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001437749-26-004876.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Natural Health Trends Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
RENAISSANCE TECHNOLOGIES LLC2026-06-30$963.0k544,077Reduced−11,338
BlackRock, Inc.2026-06-30$169.2k95,588Reduced−20,546
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$155.8k88,011Reduced−18,016
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$135.6k76,604Unchanged
CITADEL ADVISORS LLC2026-06-30$67.1k37,888Added+4,474
VANGUARD FIDUCIARY TRUST CO2026-06-30$61.8k34,905Unchanged
JANE STREET GROUP, LLC2026-06-30$61.1k34,545New+34,545
STATE STREET CORP2026-06-30$47.8k27,012Unchanged
DIMENSIONAL FUND ADVISORS LP2026-06-30$40.8k23,075Reduced−4,222
BRIDGEWAY CAPITAL MANAGEMENT, LLC2026-06-30$40.0k22,600Unchanged

Recent filings

All 522 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Natural Health Trends Corp, recent filings
FiledFormWhat it isAccession number
2026-10-2809:20 ET10-QQuarterly reportPeriod 2026-09-300001437749-26-033713
2026-10-2809:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-033711
2026-07-2909:20 ET10-QQuarterly reportPeriod 2026-06-300001437749-26-024770
2026-07-2909:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-024763
2026-05-0714:39 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001437749-26-015500
2026-04-2909:20 ET10-QQuarterly reportPeriod 2026-03-310001437749-26-013744
2026-04-2909:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-013743
2026-03-2414:28 ETDEF 14AProxy statementPeriod 2026-05-070001437749-26-009523
2026-03-2412:00 ETDEF 14AProxy statementPeriod 2026-05-070001437749-26-009522
2026-02-2013:45 ET10-KAnnual reportPeriod 2025-12-310001437749-26-004876

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 20, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
912061
Tickers
NHTC
Exchange
Nasdaq
SIC code
5190 Wholesale-Miscellaneous Nondurable Goods
Sector
Consumer discretionary
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 09:27 ET. Listed shows no prices and gives no investment advice.